Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
The LASER-AD study provides limited reassurance in relation to the occasional prescription of novel antipsychotics to elderly people with dementia
For psychiatrists in the business of helping old people who exhibit delusions and challenging behaviours related to dementia, it will be a relief to read some good news at last. Apparently, even if we may not be helping old people with dementia very much when we treat them with an atypical antipsychotic,1 we may after all not be hastening their deaths or irreversibly …
Competing interests: DA has received research support, assistance to attend conferences, and honoraria for lectures and consultancy services from companies which market antipsychotic drugs, including Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Janssen Cilag, Novartis and Pfizer.